Based on these results, it can be concluded that after four weeks of Ang II administration, visible AAAs were induced in mice, along with the promotion of M1 and M2 macrophage infiltration and increased TM expression at the lesion site. The gene discussed is AGT; the disease is achalasia-alacrima syndrome.